China Infrastructure Construction Corp. (CHNC) Research

China Infrastructure Construction Corp. (CHNC), founded in Houston, Texas, in 2003, is primarily an educational provider specializing in medical cannabis. The company delivers its cannabis-focused curricula throughout the United States and Latin America, also offering worldwide access via online platforms. Beyond its educational endeavors, CHNC furnishes a range of therapeutic services. These include the execution of clinical trials and the operation of a dedicated fertility and sleep center situated in Houston, Texas. This center specifically addresses sleep-related conditions, particularly those that result in infertility. Additionally, through its division, Pharmacology University, CHNC provides a comprehensive array of services related to medical cannabis, including instruction, advisory support, digital content creation, promotional activities, and licensing for franchise operations.

Market snapshot

Symbol
CHNC
Price
$0.00
Day change
+14.94%
Market cap
$5.0M
P/E ratio
-20.53x
52-week range
3.9E-4-0.0022
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acreage Holdings, Inc. (ACRDF)
  • Acreage Holdings, Inc. (ACRHF)
  • The BC Bud Corporation (BCBCF)
  • CLS Holdings USA, Inc. (CLSH)
  • Fire & Flower Holdings Corp. (FFLWF)
  • Guardion Health Sciences, Inc. (GHSI)
  • Epsilon Healthcare Limited (HDRPF)
  • Invictus MD Strategies Corp. (IVITF)

Open China Infrastructure Construction Corp. (CHNC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.